Frank Hong

3.1k total citations · 2 hit papers
19 papers, 2.5k citations indexed

About

Frank Hong is a scholar working on Oncology, Ophthalmology and Molecular Biology. According to data from OpenAlex, Frank Hong has authored 19 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Ophthalmology and 6 papers in Molecular Biology. Recurrent topics in Frank Hong's work include Cancer-related Molecular Pathways (11 papers), Ocular Oncology and Treatments (7 papers) and Virus-based gene therapy research (3 papers). Frank Hong is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), Ocular Oncology and Treatments (7 papers) and Virus-based gene therapy research (3 papers). Frank Hong collaborates with scholars based in United States, China and Taiwan. Frank Hong's co-authors include Robert Bookstein, Jin‐Yuh Shew, Wen‐Hwa Lee, Eva Y.-H.P. Lee, Larry A. Donoso, Theodore W. Sery, Gary L. Clayman, C Allred, Steven A. Madreperla and Pascale Rio and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Frank Hong

18 papers receiving 2.4k citations

Hit Papers

Human Retinoblastoma Susceptibility Gene: Cloning, Identi... 1987 2026 2000 2013 1987 1987 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Hong United States 13 1.4k 1.2k 880 505 364 19 2.5k
Peter Scully United States 7 1.4k 1.0× 1.1k 0.9× 587 0.7× 443 0.9× 266 0.7× 8 2.0k
Aart G. Jochemsen Netherlands 34 2.0k 1.4× 2.8k 2.2× 322 0.4× 391 0.8× 483 1.3× 70 3.7k
Vikas Khetan India 21 603 0.4× 825 0.7× 1.0k 1.2× 110 0.2× 290 0.8× 119 1.8k
R A Weinberg United States 21 1.3k 0.9× 1.8k 1.5× 129 0.1× 342 0.7× 322 0.9× 33 2.5k
Barbara Faha United States 15 1.6k 1.2× 1.7k 1.4× 212 0.2× 637 1.3× 335 0.9× 19 2.5k
Nicolas Janin France 19 620 0.5× 818 0.7× 116 0.1× 358 0.7× 314 0.9× 40 1.5k
Huei-Jen Su Huang United States 6 555 0.4× 631 0.5× 190 0.2× 252 0.5× 159 0.4× 7 1.2k
Jane Weaver-Feldhaus United States 10 1.8k 1.3× 1.9k 1.5× 81 0.1× 294 0.6× 757 2.1× 10 3.1k
Gloria Balaban United States 19 630 0.5× 1.0k 0.8× 107 0.1× 332 0.7× 449 1.2× 23 1.7k
O. A. Jensen Denmark 23 514 0.4× 645 0.5× 1.2k 1.3× 144 0.3× 58 0.2× 109 2.0k

Countries citing papers authored by Frank Hong

Since Specialization
Citations

This map shows the geographic impact of Frank Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Hong more than expected).

Fields of papers citing papers by Frank Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Hong. The network helps show where Frank Hong may publish in the future.

Co-authorship network of co-authors of Frank Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Hong. A scholar is included among the top collaborators of Frank Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Hong. Frank Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hong, Frank, et al.. (2025). A new strategy improving TB diagnosis: stratified urine LAM test based on lymphocyte counts. Frontiers in Cellular and Infection Microbiology. 15. 1498651–1498651. 1 indexed citations
2.
Jiang, Weiyu, Frank Hong, Ben Niu, et al.. (2025). Genome-wide analysis of apple histone acetyltransferases reveals the regulatory roles of MdHAG1 and MdHAM1 in response to abiotic stresses. Plant Science. 355. 112441–112441. 1 indexed citations
3.
4.
Hong, Frank, et al.. (2020). Tumor-specific lytic path “hyperploid progression mediated death”: Resolving side effects through targeting retinoblastoma or p53 mutant. World Journal of Clinical Oncology. 11(11). 854–867. 1 indexed citations
5.
Kudrow, David, Julio Pascual, Paul Winner, et al.. (2019). Vascular safety of erenumab for migraine prevention. Neurology. 94(5). e497–e510. 66 indexed citations
6.
Chen, Mei-Chuan, Bingsen Zhou, Keqiang Zhang, et al.. (2015). The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro. Molecular Pharmacology. 87(6). 996–1005. 23 indexed citations
7.
Hong, Frank & Gary L. Clayman. (2000). Isolation of a peptide for targeted drug delivery into human head and neck solid tumors.. PubMed. 60(23). 6551–6. 82 indexed citations
9.
Chen, Jun, Frank Hong, & Perry D. Nisen. (1997). Gene therapy for human brain tumors by ectopic overexpression of cell cycle cyclin-dependent kinase inhibitors (CDKIs) • 646. Pediatric Research. 41. 110–110. 4 indexed citations
10.
Hong, Frank, et al.. (1994). The Corral Hypothesis: A Novel Regulatory Mode for Retinoblastoma Protein Function. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 97–107. 13 indexed citations
11.
Hensey, Carmel, et al.. (1994). Identification of discrete structural domains in the retinoblastoma protein. Amino-terminal domain is required for its oligomerization.. Journal of Biological Chemistry. 269(2). 1380–1387. 54 indexed citations
12.
Hollingsworth, Robert E., et al.. (1991). RB Protein as a Cellular "Corral" for Growth-promoting Proteins. Cold Spring Harbor Symposia on Quantitative Biology. 56(0). 211–217. 30 indexed citations
13.
Hong, Frank & Wen‐Hwa Lee. (1991). Sequence similarity between part of human retinoblastoma susceptibility gene product and a neurofilament protein subunit. Bioscience Reports. 11(3). 159–163. 6 indexed citations
14.
Bookstein, Robert, Pascale Rio, Steven A. Madreperla, et al.. (1990). Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.. Proceedings of the National Academy of Sciences. 87(19). 7762–7766. 278 indexed citations
15.
Hong, Frank, Hui Huang, Ho To, et al.. (1989). Structure of the human retinoblastoma gene.. Proceedings of the National Academy of Sciences. 86(14). 5502–5506. 156 indexed citations
16.
Shew, Jin‐Yuh, et al.. (1987). The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 329(6140). 642–645. 535 indexed citations breakdown →
17.
Lee, Wen‐Hwa, et al.. (1987). Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence. Science. 235(4794). 1394–1399. 1113 indexed citations breakdown →
18.
Niesters, Hubert G.M., Johannes A. Lenstra, Willy J. M. Spaan, et al.. (1986). The peplomer protein sequence of the M41 strain of coronavirus IBV and its comparison with Beaudette strains. Virus Research. 5(2-3). 253–263. 70 indexed citations
19.
Vora, Shobhana, et al.. (1986). Isolation of a cDNA for human muscle 6-phosphofructokinase. Biochemical and Biophysical Research Communications. 135(2). 615–621. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026